Probability of Positive ROI with ATE - Jan 22. Market CloseHi longs,
Curious as to what the almost insiders that know this company inside out think of the following from the current entry point today (say $4.00 to keep round numbers):
Projected 1-year ROI =
Projected 3-year ROI =
Projected 5-year ROI =
Based on your calculated risk, kindly state probability of achieving projected ROIs (low, average, or high probability).
From a tax efficiency prespective, is it fair to say, ATE.TO via TFSA, RRSP, or other tax efficient vehicle could be one of the best Canadian companies to invest in right now for investors looking long-term? Where if you can afford to hold for 3-5 years, it is a very low risk investment with a tremendous short-term and long-term upside?
On my assessment it looks like the long-term ROI is in the range of 10x to 300x+ from market close January 22, 2021, where after the COVID storm, there will be a natural lift on NASDAQ timed to capital markets where Antibe Holdings will be pursuing multiple lines of therapeutics in their pipeline in the following markets:
1. Chronic Pain (Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis)
2. Inflammatory Bowel Disease (Ulcerative Colitis and Crohn's Disease)
Will we see a jump in the SP once amalgamated with Antibe Holdings, because now the key has opened the lock where the combined entity value jumps (amalgamation, market marker opens at new SP)?
Have a great weekend everyone! GLTA